This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Michelle Kaupas: Innovator in Chimeric Human Papillomavirus Research
Introduction
Michelle Kaupas is a notable inventor based in Plymouth Meeting, PA (US). She has made significant contributions to the field of virology, particularly in the development of chimeric human papillomavirus (HPV). Her innovative work has implications for both research and therapeutic applications.
Latest Patents
Michelle Kaupas holds 1 patent related to the production of infectious chimeric papillomaviruses. This invention focuses on chimeric viruses where the early genes are derived from HPV 18, while the late genes come from another HPV strain. Additionally, her patent includes methods for culturing the virus in raft cell cultures and assays that utilize these chimeric viruses.
Career Highlights
Kaupas is currently employed at Merck & Co., Inc., a leading global healthcare company. Her role at Merck allows her to work on cutting-edge research and development projects that aim to advance the understanding and treatment of HPV-related diseases.
Collaborations
Throughout her career, Michelle has collaborated with esteemed colleagues, including Robert S. Lowe and Craig M. Meyers. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field of virology.
Conclusion
Michelle Kaupas is a pioneering inventor whose work on chimeric human papillomavirus has the potential to impact the medical field significantly. Her contributions to virology exemplify the importance of innovation in addressing public health challenges.